Clinical Trial Update: Synthetic Genistein (BONISTEIN™) in Patients Who Are Undergoing Surgery for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update evaluating synthetic genistein (BONISTEIN) in patients undergoing surgery for prostate cancer. The current status of the trial is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• BONISTEIN (genistein)

Snippet

Sponsor: University Hospital, Aker | Conditions: Prostatic Neoplasms | Phase 2 | Status: UNKNOWN